Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Turning FDA's 'Clunky' Drug Database Into A Useable Goldmine

Executive Summary

The FDA's drug database, Drugs@FDA, is a goldmine of information. Unfortunately, because of the agency's "clunky" website, the data are difficult to access, search and aggregate, so the information's value is largely lost. But a group of scientists are using an $80,000 Open Science Prize to try to change that aggravating situation.


Related Content

US Capitol Capsule: Cancer Therapies, Orphan Drugs Dominated 2015 Approvals; PCSK9s Arrived
US Capitol Capsule: 2014: a year for orphan drugs, anti-PD-1s, 2nd chancers
2013 was springboard for 'breakthrough' drugs


Related Companies

Related Deals

What to read next




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts